Diabetes and coronary heart disease: A risk factor for the global epidemic

International Journal of Hypertension

Volumn 2012, Issue , 2012, Pages

  Chiha, Maguy ^a   Njeim, Mario ^b   Chedrawy, Edgar G ^c  

^a LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^b HENRY FORD HOSPITAL   (United States)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; ATENOLOL; CAPTOPRIL; FIBRINOLYTIC AGENT; NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; PLACEBO; REACTIVE OXYGEN METABOLITE;

ATHEROGENESIS; BLOOD CLOTTING; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; DEVELOPING COUNTRY; DIABETES MELLITUS; DIABETIC PATIENT; EPIDEMIC; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOGENESIS; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; THROMBOCYTE DYSFUNCTION; UNITED STATES;

EID: 84869045623     PISSN: 20900384     EISSN: 20900392     Source Type: Journal    
DOI: 10.1155/2012/697240     Document Type: Review

References (61)

1. Gaziano T. A., Cardiovascular disease in the developing world and its cost-effective management. Circulation 2005 112 23 3547 3553 2-s2.0-33644878249 10.1161/CIRCULATIONAHA.105.591792 (Pubitemid 43739531)
2. Rosamond W., Flegal K., Friday G., Heart disease and stroke statistics - 2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2007 115 5 e69 e171 (Pubitemid 46226160)
3. Capewell S., Morrison C. E., McMurray J. J., Contribution of modern cardiovascular treatment and risk factor changes to the decline in coronary heart disease mortality in Scotland between 1975 and 1994. Heart 1999 81 4 380 386 2-s2.0-0032923347 (Pubitemid 29167127)
4. Unal B., Critchley J. A., Capewell S., Modelling the decline in coronary heart disease deaths in England and Wales, 1981-2000: comparing contributions from primary prevention and secondary prevention. British Medical Journal 2005 331 7517 614 617 2-s2.0-24944581693 10.1136/bmj.38561.633345.8F (Pubitemid 41360776)
5. Capewell S., Beaglehole R., Seddon M., McMurray J., Explanation for the decline in coronary heart disease mortality rates in Auckland, New Zealand, between 1982 and 1993. Circulation 2000 102 13 1511 1516 2-s2.0-0034718443
6. Critchley J., Liu J., Zhao D., Wei W., Capewell S., Explaining the increase in coronary heart disease mortality in Beijing between 1984 and 1999. Circulation 2004 110 10 1236 1244 2-s2.0-4444347411 10.1161/01.CIR.0000140668. 91896.AE (Pubitemid 39202339)
7. Ford E. S., Ajani U. A., Croft J. B., Critchley J. A., Labarthe D. R., Kottke T. E., Giles W. H., Capewell S., Explaining the decrease in U.S. deaths from coronary disease, 1980-2000. The New England Journal of Medicine 2007 356 23 2388 2398 2-s2.0-34848913240 10.1056/NEJMsa053935 (Pubitemid 46883773)
8. Fuster V., Voute J., Hunn M., Smith S. C., Low priority of cardiovascular and chronic diseases on the global health agenda: a cause for concern. Circulation 2007 116 17 1966 1970 2-s2.0-37349046019 10.1161/CIRCULATIONAHA.107. 733444 (Pubitemid 350287092)
9. Poulsen M. K., Henriksen J. E., Dahl J., Johansen A., Gerke O., Vach W., Haghfelt T., Hoilund-Carlsen P. F., Beck-Nielsen H., Moller J. E., Left ventricular diastolic function in type 2 diabetes mellitus prevalence and association with myocardial and vascular disease. Circulation: Cardiovascular Imaging 2010 3 1 24 31 2-s2.0-75749104166 10.1161/CIRCIMAGING.109.855510
10. Huxley R. R., Filion K. B., Konety S., Alonso A., Meta-analysis of cohort and case-control studies of type 2 diabetes mellitus and risk of atrial fibrillation. American Journal of Cardiology 2011 108 1 56 62 2-s2.0-79958814579 10.1016/j.amjcard.2011.03.004
11. Kannel W. B., McGee D. L., Diabetes and cardiovascular risk factors: the framingham study. Circulation 1979 59 1 8 13 2-s2.0-0018341014 (Pubitemid 9082394)
12. Schnohr P., Lange P., Scharling H., Skov Jensen J., Long-term physical activity in leisure time and mortality from coronary heart disease, stroke, respiratory diseases, and cancer. The Copenhagen City Heart Study. European Journal of Cardiovascular Prevention and Rehabilitation 2006 13 2 173 179 2-s2.0-33746254116 10.1097/01.hjr.0000198923.80555.b7 (Pubitemid 44097720)
13. Berry J. D., Dyer A., Cai X., Lifetime risks of cardiovascular disease. The New England Journal of Medicine 2012 366 4 321 329 10.1056/NEJMoa1012848
14. Lee W. L., Cheung A. M., Cape D., Zinman B., Impact of diabetes on coronary artery disease in women and men: a meta- analysis of prospective studies. Diabetes Care 2000 23 7 962 968 2-s2.0-0033911688 (Pubitemid 30480024)
15. Nielson C., Lange T., Hadjokas N., Blood glucose and coronary artery disease in nondiabetic patients. Diabetes Care 2006 29 5 998 1001 2-s2.0-33746342154 10.2337/diacare.295998 (Pubitemid 44115234)
16. King H., Aubert R. E., Herman W. H., Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 1998 21 9 1414 1431 2-s2.0-0031752685 (Pubitemid 28405191)
17. Yusuf P. S., Hawken S., Ôunpuu S., Dans T., Avezum A., Lanas F., McQueen M., Budaj A., Pais P., Varigos J., Lisheng L., Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. The Lancet 2004 364 9438 937 952 2-s2.0-9644262614 10.1016/S0140-6736(04)17018-9 (Pubitemid 39208455)
18. Silva J. A., Eseobar A., Collins T. J., Ramee S. R., White C. J., Unstable angina: a comparison of angioscopic findings between diabetic and nondiabetic patients. Circulation 1995 92 7 1731 1736 2-s2.0-0029124112
19. Moreno P. R., Murcia A. M., Palacios I. F., Leon M. N., Bernardi V. H., Fuster V., Fallon J. T., Coronary composition and macrophage infiltration in atherectomy specimens from patients with diabetes mellitus. Circulation 2000 102 18 2180 2184 2-s2.0-0034739458
20. Beckman J. A., Creager M. A., Libby P., Diabetes and atherosclerosis epidemiology, pathophysiology, and management. Journal of the American Medical Association 2002 287 19 2570 2581 2-s2.0-0037092995 (Pubitemid 34517204)
21. D'Souza A., Hussain M., Howarth F. C., Woods N. M., Bidasee K., Singh J., Pathogenesis and pathophysiology of accelerated atherosclerosis in the diabetic heart. Molecular and Cellular Biochemistry 2009 331 1-2 89 116 2-s2.0-74049135423 10.1007/s11010-009-0148-8
22. Moreno P. R., Purushothaman K. R., Fuster V., Echeverri D., Truszczynska H., Sharma S. K., Badimon J. J., O'Connor W. N., Plaque neovascularization is increased in ruptured atherosclerotic lesions of human aorta: implications for plaque vulnerability. Circulation 2004 110 14 2032 2038 2-s2.0-4944229954 10.1161/01.CIR.0000143233.87854.23 (Pubitemid 39331918)
23. Shechter M., Bairey Merz C. N., Paul-Labrador M. J., Kaul S., Blood glucose and platelet-dependent thrombosis in patients with coronary artery disease. Journal of the American College of Cardiology 2000 35 2 300 307 2-s2.0-0034005649 10.1016/S0735-1097(99)00545-8 (Pubitemid 30125517)
24. Schneider D. J., Sobel B. E., Augmentation of synthesis of plasminogen activator inhibitor type 1 by insulin and insulin-like growth factor type I: implications for vascular disease in hyperinsulinemic states. Proceedings of the National Academy of Sciences of the United States of America 1991 88 22 9959 9963 2-s2.0-0026531743 (Pubitemid 21915754)
25. McGill J. B., Schneider D. J., Arfken C. L., Lucore C. L., Sobel B. E., Factors responsible for impaired fibrinolysis in obese subjects and NIDDM patients. Diabetes 1994 43 1 104 109 2-s2.0-0028008336
26. Hypertension in Diabetes Study (HDS): I. Prevalence of hypertension in newly presenting type 2 diabetic patients and the association with risk factors for cardiovascular and diabetic complications. Journal of Hypertension 1993 11 3 309 317 2-s2.0-0027286024
27. Muntzel M. S., Anderson E. A., Johnson A. K., Mark A. L., Mechanisms of insulin action on sympathetic nerve activity. Clinical and Experimental Hypertension 1995 17 1-2 39 50 2-s2.0-0028840194
28. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. British Medical Journal 1998 317 7160 703 713 2-s2.0-0033514015
29. Patel A., Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial. The Lancet 2007 370 9590 829 840 2-s2.0-34548420712 10.1016/S0140-6736(07)61303-8 (Pubitemid 47362321)
30. Executive summary: standards of medical care in diabetes - 2010. Diabetes Care 2010 33 supplement 1 S4 S10
31. Chobanian A. V., Bakris G. L., Black H. R., Cushman W. C., Green L. A., Izzo J. L., Jones D. W., Materson B. J., Oparil S., Wright J. T., Roccella E. J., The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. Journal of the American Medical Association 2003 289 19 2560 2572 2-s2.0-0038460302 10.1001/jama.289.19.2560 (Pubitemid 37430158)
32. Bakris G. L., Williams M., Dworkin L., Elliott W. J., Epstein M., Toto R., Tuttle K., Douglas J., Hsueh W., Sowers J., Willis K., Preserving renal function in adults with hypertension and diabetes: a consensus approach. American Journal of Kidney Diseases 2000 36 3 646 661 2-s2.0-0033852481
33. Pop-Busui R., Evans G. W., Gerstein H. C., Fonseca V., Fleg J. L., Hoogwerf B. J., Genuth S., Grimm R. H., Corson M. A., Prineas R., Effects of cardiac autonomic dysfunction on mortality risk in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Diabetes Care 2010 33 7 1578 1584 2-s2.0-77956582081 10.2337/dc10-0125
34. Howard B. V., Roman M. J., Devereux R. B., Fleg J. L., Galloway J. M., Henderson J. A., Howard W. J., Lee E. T., Mete M., Poolaw B., Ratner R. E., Russell M., Silverman A., Stylianou M., Umans J. G., Wang W., Weir M. R., Weissman N. J., Wilson C., Yeh F., Zhu J., Effect of lower targets for blood pressure and LDL cholesterol on atherosclerosis in diabetes: the SANDS randomized trial. Journal of the American Medical Association 2008 299 14 1678 1689 2-s2.0-41949101956 10.1001/jama.299.14.1678 (Pubitemid 351519865)
35. Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation 2002 106 25 3143 3421
36. Pearson T. A., Blair S. N., Daniels S. R., Eckel R. H., Fair J. M., Fortmann S. P., Franklin B. A., Goldstein L. B., Greenland P., Grundy S. M., Hong Y., Miller N. H., Lauer R. M., Ockene I. S., Sacco R. L., Sallis J. F., Smith S. C., Stone N. J., Taubert K. A., AHA guidelines for primary prevention of cardiovascular disease and stroke: 2002 update: consensus panel guide to comprehensive risk reduction for adult patients without coronary or other atherosclerotic vascular diseases. Circulation 2002 106 3 388 391 2-s2.0-0037118660 10.1161/01.CIR.0000020190.45892.75 (Pubitemid 34778969)
37. Haffner S. M., Lehto S., Rönnemaa T., Pyörälä K., Laakso M., Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. The New England Journal of Medicine 1998 339 4 229 234 2-s2.0-0032560807 10.1056/NEJM199807233390404 (Pubitemid 28350165)
38. Booth G. L., Kapral M. K., Fung K., Tu J. V., Relation between age and cardiovascular disease in men and women with diabetes compared with non-diabetic people: a population-based retrospective cohort study. The Lancet 2006 368 9529 29 36 2-s2.0-33745400514 10.1016/S0140-6736(06)68967-8 (Pubitemid 43947203)
39. Wilson P. W. F., D'Agostino R. B., Levy D., Belanger A. M., Silbershatz H., Kannel W. B., Prediction of coronary heart disease using risk factor categories. Circulation 1998 97 18 1837 1847 2-s2.0-0032510639 (Pubitemid 28213628)
40. Stevens R. J., Kothari V., Adler A. I., Stratton I. M., Holman R. R., The UKPDS risk engine: a model for the risk of coronary heart disease in type II diabetes (UKPDS 56). Clinical Science 2001 101 6 671 679 2-s2.0-0035212615 10.1042/CS20000335 (Pubitemid 33135349)
41. Eddy D. M., Schlessinger L., Archimedes: a trial-validated model of diabetes. Diabetes Care 2003 26 11 3093 3101 2-s2.0-0242300709 10.2337/diacare.26.11.3093 (Pubitemid 37339504)
42. Mak K. H., Moliterno D. J., Granger C. B., Influence of diabetes mellitus on clinical outcome in the thrombolytic era of acute myocardial infarction. GUSTO-I Investigators. Global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries. Journal of the American College of Cardiology 1997 30 1 171 179 10.1016/S0735-1097(97)00118-6 (Pubitemid 27357143)
43. Zuanetti G., Latini R., Maggioni A. P., Santoro L., Franzosi M. G., Influence of diabetes on mortality in acute myocardial infarction: data from the GISSI-2 study. Journal of the American College of Cardiology 1993 22 7 1788 1794 2-s2.0-0027370468 (Pubitemid 23359632)
44. Aguilar D., Solomon S. D., Koober L., Rouleau J. L., Skali H., McMurray J. J. V., Francis G. S., Henis M., O'Connor C. M., Diaz R., Belenkov Y. N., Varshavsky S., Leimberger J. D., Velazquez E. J., Califf R. M., Pfeffer M. A., Newly diagnosed and previously known diabetes mellitus and 1-year outcomes of acute myocardial infarction: The Valsartan in acute myocardial infarction (VALIANT) trial. Circulation 2004 110 12 1572 1578 2-s2.0-20844456796 10.1161/01.CIR.0000142047.28024.F2 (Pubitemid 39297978)
45. Timmer J. R., Ottervanger J. P., de Boer M. J., Boersma E., Grines C. L., Westerhout C. M., Simes R. J., Granger C. B., Zijlstra F., Primary percutaneous coronary intervention compared with fibrinolysis for myocardial infarction in diabetes mellitus: results from the primary coronary angioplasty vs thrombolysis-2 trial. Archives of Internal Medicine 2007 167 13 1353 1359 2-s2.0-34447339953 10.1001/archinte.167.13.1353 (Pubitemid 47052432)
46. Malmberg K., Yusuf S., Gerstein H. C., Brown J., Zhao F., Hunt D., Piegas L., Calvin J., Keltai M., Budaj A., Impact of diabetes on long-term prognosis in patients with unstable angina and non-Q-wave myocardial infarction: results of the OASIS (Organization to Assess Strategies for Ischemic Syndromes) registry. Circulation 2000 102 9 1014 1019 2-s2.0-0034730110 (Pubitemid 30656008)
47. Vinik A. I., Maser R. E., Mitchell B. D., Freeman R., Diabetic autonomic neuropathy. Diabetes Care 2003 26 5 1553 1579 2-s2.0-0042405193 10.2337/diacare.26.5.1553 (Pubitemid 36934465)
48. Anand D. V., Lim E., Hopkins D., Corder R., Shaw L. J., Sharp P., Lipkin D., Lahiri A., Risk stratification in uncomplicated type 2 diabetes: prospective evaluation of the combined use of coronary artery calcium imaging and selective myocardial perfusion scintigraphy. European Heart Journal 2006 27 6 713 721 2-s2.0-32044446172 10.1093/eurheartj/ehi808
49. Wackers F. J. T., Young L. H., Inzucchi S. E., Chyun D. A., Davey J. A., Barrett E. J., Taillefer R., Wittlin S. D., Heller G. V., Filipchuk N., Engel S., Ratner R. E., Iskandrian A. E., Detection of silent myocardial ischemia in asymptomatic diabetic subjects: the DIAD study. Diabetes Care 2004 27 8 1954 1961 2-s2.0-3342948360 10.2337/diacare.27.8.1954 (Pubitemid 38989238)
50. Scognamiglio R., Negut C., Ramondo A., Tiengo A., Avogaro A., Detection of coronary artery disease in asymptomatic patients with type 2 diabetes mellitus. Journal of the American College of Cardiology 2006 47 1 65 71 2-s2.0-29344470555 10.1016/j.jacc.2005.10.008 (Pubitemid 43005166)
51. Frye R. L., August P., Brooks M. M., A randomized trial of therapies for type 2 diabetes and coronary artery disease. The New England Journal of Medicine 2009 360 24 2503 2515 10.1056/NEJMoa0805796
52. Young L. H., Wackers F. J. T., Chyun D. A., Davey J. A., Barrett E. J., Taillefer R., Heller G. V., Iskandrian A. E., Wittlin S. D., Filipchuk N., Ratner R. E., Inzucchi S. E., Cardiac outcomes after screening for asymptomatic coronary artery disease in patients with type 2 diabetes the DIAD study: a randomized controlled trial. Journal of the American Medical Association 2009 301 15 1547 1555 2-s2.0-64749092606 10.1001/jama.2009.476
53. Gibbons R. J., Balady G. J., Bricker J. T., Bricker J. T., Chaitman B. R., Fletcher G. F., Froelicher V. F., Mark D. B., McCallister B. D., Mooss A. N., O'Reilly M. G., Winters W. L., Antman E. M., Antman E. M., Alpert J. S., Alpert J. S., Faxon D. P., Faxon D. P., Fuster V., Fuster V., Gregoratos G., Gregoratos G., Hiratzka L. F., Hiratzka L. F., Jacobs A. K., Jacobs A. K., Russell R. O., Russell R. O., Smith S. C., Smith S. C., Smith S. C., ACC/AHA 2002 guideline update for exercise testing: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to update the 1997 exercise testing guidelines). Journal of the American College of Cardiology 2002 40 8 1531 1540 2-s2.0-0037120984 10.1016/S0735-1097(02)02164-2 (Pubitemid 35192881)
54. Greenland P., Alpert J. S., Beller G. A., Benjamin E. J., Budoff M. J., Fayad Z. A., Foster E., Hlatky M. A., Hodgson J. M., Kushner F. G., Lauer M. S., Shaw L. J., Smith S. C., Taylor A. J., Weintraub W. S., Wenger N. K., 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the american college of cardiology foundation/american heart association task force on practice guidelines. Circulation 2010 122 25 e584 e636 2-s2.0-78650709475 10.1161/CIR.0b013e3182051b4c
55. Standards of medical care in diabetes - 2012. Diabetes Care 2012 35 supplement 1 S11 S63
56. Wild S., Roglic G., Green A., Sicree R., King H., Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004 27 5 1047 1053 2-s2.0-2342466734 10.2337/diacare.27.5.1047 (Pubitemid 38579764)
57. King H., Rewers M., Global estimates for prevalence of diabetes mellitus and impaired glucose tolerance in adults. Diabetes Care 1993 16 1 157 177 2-s2.0-0027532914 (Pubitemid 23013841)
58. Shaw J. E., Sicree R. A., Zimmet P. Z., Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Research and Clinical Practice 2010 87 1 4 14 2-s2.0-73749083481 10.1016/j.diabres.2009.10.007
59. Yusuf S., Islam S., Chow C. K., Rangarajan S., Dagenais G., Diaz R., Gupta R., Kelishadi R., Iqbal R., Avezum A., Kruger A., Kutty R., Lanas F., Liu L., Wei L., Lopez-Jaramillo P., Oguz A., Rahman O., Swidan H., Yusoff K., Zatonski W., Rosengren A., Teo K. K., Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiological survey. The Lancet 2011 378 9798 1231 1243 2-s2.0-80053563341 10.1016/S0140-6736(11)61215-4
60. Fitch K., Lázaro P., Aguilar M. D., Kahan J. P., Van Het Loo M., Bernstein S. J., European criteria for the appropriateness and necessity of coronary revascularization procedures. European Journal of Cardio-thoracic Surgery 2000 18 4 380 387 2-s2.0-0342844371 10.1016/S1010-7940(00)00530-3
61. Kapur A., Hall R. J., Malik I. S., Qureshi A. C., Butts J., de Belder M., Baumbach A., Angelini G., de Belder A., Oldroyd K. G., Flather M., Roughton M., Nihoyannopoulos P., Bagger J. P., Morgan K., Beatt K. J., Randomized comparison of percutaneous coronary intervention with coronary artery bypass grafting in diabetic patients. 1-Year Results of the CARDia (Coronary Artery Revascularization in Diabetes) trial. Journal of the American College of Cardiology 2010 55 5 432 440 2-s2.0-74549225627 10.1016/j.jacc.2009.10.014